MINISINI, Rosalba
 Distribuzione geografica
Continente #
EU - Europa 2.486
NA - Nord America 1.639
AS - Asia 634
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 4
Totale 4.779
Nazione #
US - Stati Uniti d'America 1.621
IE - Irlanda 747
IT - Italia 528
DE - Germania 316
SE - Svezia 302
UA - Ucraina 198
HK - Hong Kong 194
FR - Francia 144
CN - Cina 140
SG - Singapore 140
IN - India 112
FI - Finlandia 110
CZ - Repubblica Ceca 91
GB - Regno Unito 18
CA - Canada 17
IR - Iran 16
TR - Turchia 15
BE - Belgio 14
VN - Vietnam 11
EU - Europa 8
KE - Kenya 5
RU - Federazione Russa 5
EG - Egitto 3
KR - Corea 3
NL - Olanda 3
BR - Brasile 2
CL - Cile 2
ES - Italia 2
LT - Lituania 2
AM - Armenia 1
BG - Bulgaria 1
CH - Svizzera 1
HU - Ungheria 1
JP - Giappone 1
PA - Panama 1
PL - Polonia 1
PT - Portogallo 1
RO - Romania 1
UZ - Uzbekistan 1
Totale 4.779
Città #
Dublin 735
Jacksonville 368
Hong Kong 194
Dearborn 182
Chandler 132
Singapore 106
Piemonte 97
Novara 95
Wilmington 87
Lawrence 81
Princeton 81
Ann Arbor 67
San Mateo 59
Beijing 56
Milan 51
Andover 38
Ashburn 36
Turin 36
Brno 35
Vercelli 33
Pardubice 32
Munich 28
Boardman 25
Bremen 21
Nanjing 19
Düsseldorf 15
Brussels 14
České Budějovice 14
Helsinki 12
Santa Clara 11
Dong Ket 10
Houston 10
Mülheim 10
Cassano Magnago 9
Jinan 9
Norwalk 9
Seattle 9
Stankov 8
West Jordan 8
Brescia 7
Hefei 7
Palermo 7
Toronto 7
Fairfield 6
Kunming 6
Strasbourg 6
Alessandria 5
Bologna 5
Grafing 5
Guangzhou 5
Kocaeli 5
Leawood 5
Nairobi 5
Ottawa 5
Rome 5
Ardabil 4
Borgomanero 4
Canegrate 4
Menlo Park 4
Nanchang 4
Odalengo Grande 4
Oleggio 4
Philadelphia 4
Zanjan 4
Zhengzhou 4
Augusta 3
Bari 3
Berlin 3
Borgo Vercelli 3
Costa Masnaga 3
Fuzhou 3
Gangnam-gu 3
Genoa 3
Leipzig 3
Los Angeles 3
Mondovì 3
Monmouth Junction 3
Ningbo 3
Nuremberg 3
Torino 3
Venice 3
Winnipeg 3
Amsterdam 2
Baltimore 2
Bergamo 2
Cassano 2
Castellammare di Stabia 2
Cumiana 2
Espoo 2
Frankfurt am Main 2
Ghemme 2
Gunzenhausen 2
Hebei 2
Izmir 2
Lucca 2
Madrid 2
Moncalieri 2
Monza 2
Prague 2
Quarrata 2
Totale 3.060
Nome #
Japanese encephalitis virus RNA detected in Culex pipiens mosquitoes in Italy 95
Gas6 as a predictor of esophageal varices in patients affected by hepatitis C virus related-chronic liver disease 95
Levosimendan inhibits peroxidation in hepatocytes by modulating apoptosis/autophagy interplay. 85
Antiviral treatment of hepatitis C improves glucose metabolism along the entire spectrum from normal glucose tolerance to diabetes 82
rs1801253 Gly/Gly carriage in the ADRB1 gene leads to unbalanced cardiac sympathetic modulation as assessed by spectral analysis of heart rate variability 80
Influence of age on sex-related differences among patients with hepatitis C. 79
Treatment failure after interferon-free treatment of hepatitis C as a clue of a yet undetected hepatocellular carcinoma 79
Interferon alpha concentrations in blood and peritoneal fluid during treatment for hepatitis C 75
17,β-estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycle 74
Analysis of beta1 and beta2-adrenergic receptors polymorphism in patients with apical ballooning cardiomyopathy 69
Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma 68
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 68
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 67
Oxidative Stress in Non-Alcoholic Fatty Liver Disease 65
Severity of nonalcoholic fatty liver disease in type 2 diabetes mellitus: Relationship between nongenetic factors and PNPLA3/HSD17B13 polymorphisms 64
Gas6 as a putative noninvasive biomarker of hepatic fibrosis 63
Cardiac dysfunction as an early predictor of portal hypertension in chronic hepatitis C 62
Can apical ballooning cardiomyopathy and anterior STEMI be differentiated based on β1 and β2-adrenergic receptors polymorphisms? 62
Influence of angiotensin-converting enzyme I/D gene polymorphism on clinical and histological correlates of chronic hepatitis C 61
Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma 61
IL28B Polymorphism, Blood Interferon-alpha Concentration, and Disease Stage of HCV Mono-infected and HCV-HIV Co-infected Patients. 60
Fibrosis Progression in HCV Carriers with Mild Hepatitis Who Possess the High-Repetition Variant of the DRD4 Gene, a Genetic Marker for Binge-Drinking and Risk-Seeking Behavior: A Longitudinal Study. 60
Combinatorial use of single nucleotide polymorphisms to help predict liver fibrosis in patients with hepatitis C infections 60
Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of the AST to platelet ratio index 59
APOLIPOPROTEIN E GENOTYPES MODULATE FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C AND PERSISTENTLY NORMAL TRANSAMINASES 59
Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients 59
Liver stiffness, not fat liver content, predicts the length of QTc interval in patients with chronic liver disease 57
ACE genotype, body weight changes and target organ damage in renal transplant recipients 57
Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein 57
Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial 56
Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease 56
Modulation of Oxidative Stress by 17 β-Estradiol and Genistein in Human Hepatic Cell Lines In Vitro 55
Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort 54
Early activation of interferon-stimulated genes in human liver allografts: relationship with acute rejection and histological outcome 54
Carriage of the apolipoprotein E-epsilon4 allele and histologic outcome of recurrent hepatitis C after antiviral treatment 54
Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients 54
Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naïve patients with chronic lymphocytic leukemia 53
CGRP Plasma Levels Correlate with the Clinical Evolution and Prognosis of Hospitalized Acute COVID-19 Patients 52
Evaluation of donor hepatic iron concentration as a factor of early fibrotic progression after liver transplantation 52
Interferon-stimulated gene pathways in the treatment of viral hepatitis 52
Detrimental Impact of Interferon-Based Regimens for Chronic Hepatitis C on Vitamin D/Parathyroid Hormone Homeostasis 52
HBV AND LYMPHOMAGENESIS: NOVEL INSIGHTS INTO AN OCCULT RELATIONSHIP 51
Clinical Relevance of Liver Involvement in the Clinical Course of Systemic Sclerosis 51
Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders 50
GENETIC POLYMORPHISM AT THE APOLIPOPROTEIN E LOCUS AFFECTS THE OUTCOME OF CHRONIC HEPATITIS B 49
Reference values of one-point carotid stiffness parameters determined by carotid echo-tracking and brachial pulse pressure in a large population of healthy subjects 49
Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs) 49
Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation 48
Recent advances in HCV entry 48
Increased Levels of ICOS and ICOSL Are Associated to Pulmonary Arterial Hypertension in Patients Affected by Connective Tissue Diseases 48
Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors 47
Low fibrosis progression of recurrent hepatitis C in apolipoprotein E epsilon4 carriers: relationship with the blood lipid profile 47
Unsuspected strongyloidiasis in hospitalized elderly patients with and without eosinophilia 47
Understanding protection from SARS-CoV-2 using metabolomics 47
INTERLEUKIN 6 PROMOTER POLYMORPHISMS INFLUENCE THE OUTCOME OF CHRONIC HEPATITIS C 47
L’impatto del Long COVID è stato minore nella terza ondata della pandemia rispetto alla prima ondata in una popolazione italiana di 324 pazienti. 45
MTHFR C677T Polymorphism and Risk of HCC in Patients With Liver Cirrhosis: Role of Male Gender and Alcohol Consumption 45
Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progression 45
Hepatitis B virus and lymphomagenesis: novel insights into an occult relationship 45
Identification of a Functional, CRM-1-Dependent Nuclear Export Signal in Hepatitis C Virus Core Protein 44
IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC 44
Usefulness of six non-proprietary indirect markers of liver fibrosis in patients with chronic hepatitis C 44
Role of Interleukin 28B rs12979860 C/T Polymorphism on the Histological Outcome of Chronic Hepatitis C: Relationship with Gender and Viral Genotype 44
GENDER-RELATED DISTRIBUTION OF THE INTERLEUKIN-1BETA AND INTERLEUKIN-1 RECEPTOR ANTAGONIST GENE POLYMORPHISMS IN PATIENTS WITH END-STAGE LIVER DISEASE 44
Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis 43
TGF-beta1 genotypes in cirrhosis: relationship with the occurrence of liver cancer 43
Prevalence and clinical relevance of occult hepatitis B virus infection in patients on the waiting list for kidney transplantation 43
Gene polymorphism at the interleukin 6 -174 G > C locus affects the outcome of chronic hepatitis B 43
Pegylated Vs. conventional interferon–alpha in antiviral regimens for recurrent hepatitis C: a comparison of tolerability and efficacy 42
Sex-related influence of angiotensin-converting enzyme polymorphisms on fibrosis progression due to recurrent hepatitis C after liver transplantation 42
INTERLEUKIN-6 POLYMORPHISMS AND GENDER: RELATIONSHIP WITH THE OCCURRENCE OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH END-STAGE LIVER DISEASE 41
Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C. 41
Circadian control of hepatitis B virus replication 41
Gas6/TAM system: potential prognostic biomarker for Multiple Sclerosis 40
Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases 40
Prevalence and risk factors for delayed adrenal insufficiency after liver transplantation. Liver Transpl. 2008 Jul;14(7):1014-9 39
Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation 39
HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment 39
Methylenetetrahydrofolate reductase C677T polymorphism and liver fibrosis progression in patients with recurrent hepatitis C 38
Weight gain after liver transplantation and the I/D polymorphism of the angiotensin-converting enzyme gene 38
Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study 37
Robust and persistent b-and t-cell responses after covid-19 in immunocompetent and solid organ transplant recipient patients 37
Genetic polymorphisms of inflammatory cytokines and liver fibrosis progression due to recurrent hepatitis C 36
Exposure to Plasma From Non-alcoholic Fatty Liver Disease Patients Affects Hepatocyte Viability, Generates Mitochondrial Dysfunction, and Modulates Pathways Involved in Fat Accumulation and Inflammation 36
Baseline plasma SARS-CoV-2 RNA detection predicts an adverse COVID-19 evolution in moderate to severe hospitalized patients 35
17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon 34
Direct antivirals and cognitive impairment in hepatitis C: a clinical-neurophysiologic study 34
Pegylated versus standard interferon-α in antiviral regimens for post-transplant recurrent hepatitis C: Comparison of tolerability and efficacy 31
Phenotypic Characteristics of the Tumour Microenvironment in Primary and Secondary Hepatocellular Carcinoma 31
Baseline Plasma Osteopontin Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients 29
Finding the seed of recurrence: Hepatocellular carcinoma circulating tumor cells and their potential to drive the surgical treatment 29
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort 28
COVID-19 Biomarkers at the Crossroad between Patient Stratification and Targeted Therapy: The Role of Validated and Proposed Parameters 28
Inflammatory Gene Expression Associates with Hepatitis B Virus cccDNA- but Not Integrant-Derived Transcripts in HBeAg Negative Disease 25
T-cell mediated responses against alpha-foetoprotein in hepatocellular carcinoma: Relationship with hepatitis C virus infection, tumour phenotype and patients’ survival 25
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma 20
Plasma Pattern of Extracellular Vesicles Isolated from Hepatitis C Virus Patients and Their Effects on Human Vascular Endothelial Cells 20
Hypoxia inducible factors regulate hepatitis B virus replication by activating the basal core promoter 20
Gas6/TAM system as potential biomarker for multiple sclerosis prognosis 19
Spleen stiffness measurement predicts decompensation and rules out high-risk oesophageal varices in primary biliary cholangitis 16
Totale 4.926
Categoria #
all - tutte 30.812
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.812


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020798 0 0 0 0 139 121 158 39 109 156 70 6
2020/2021508 65 0 67 5 78 32 74 6 75 15 77 14
2021/2022535 11 23 80 39 29 0 46 19 43 40 81 124
2022/20231.513 153 74 84 16 69 116 59 52 762 13 81 34
2023/2024919 54 108 51 25 152 39 186 29 23 43 68 141
2024/2025223 41 30 91 33 28 0 0 0 0 0 0 0
Totale 4.958